Best GLP-1 Telehealth Providers: April 2026 Rankings

The Telehealth GLP-1 Landscape in April 2026

The telehealth market for GLP-1 medications continues to evolve rapidly. With the recent FDA approval of Foundayo adding a new oral option to the mix, and the ongoing shifts in compounded medication regulations, the provider landscape looks very different than it did even three months ago. We have updated our rankings to reflect the current state of play as of early April 2026.

Our evaluation covers the major telehealth platforms that prescribe GLP-1 medications for weight loss, assessing them on pricing, medical consultation quality, medication options, patient support, and overall value. We looked at both established players and newer entrants to give you the most complete picture possible.

What We Evaluated

Each provider was assessed across five categories:

• Pricing and transparency: Monthly costs including medication, consultations, and shipping. Hidden fees were penalized.
• Medical oversight: Quality and duration of physician consultations, monitoring protocols, and prescribing practices.
• Medication options: Range of available GLP-1 medications including brand-name, compounded, and oral formulations.
• Patient experience: Ease of signup, app quality, customer support responsiveness, and refund policies.
• Foundayo availability: Whether the platform has added the newly approved oral GLP-1 to its formulary.

Pricing Overview

Monthly costs across telehealth GLP-1 providers range from roughly $99 to $500 depending on the medication, dosage, and what is included in the subscription. Here is a general breakdown of what different price tiers typically include:

• $99-$199 per month: Usually compounded semaglutide or tirzepatide, basic medical consultations, and standard shipping. Medical follow-ups may be limited or cost extra.
• $200-$349 per month: Brand-name medications with copay assistance, more thorough consultations, regular check-ins, and may include nutritional coaching or app-based support tools.
• $350-$500 per month: Premium programs with brand-name medications, comprehensive metabolic monitoring, dedicated care teams, dietitian access, and behavioral coaching. These programs position themselves as holistic weight management solutions.

It is worth noting that the cheapest option is not always the best value. Programs that skimp on medical oversight or use questionable compounding sources can end up costing more in the long run through ineffective treatment, side effect management issues, or health complications.

Provider Highlights

Ro

Ro has solidified its position as one of the leading GLP-1 telehealth providers. Their Body Program offers both compounded and brand-name semaglutide, with pricing starting around $149 per month for compounded options. Medical consultations are conducted by licensed physicians and typically last 10-15 minutes. Ro was among the first platforms to add Foundayo to its formulary following the April 1 FDA approval. Their app experience is polished and provides clear tracking of weight, medication schedules, and upcoming appointments.

Hims

Hims has undergone significant changes in its GLP-1 strategy. The widely reported partnership shifts with Novo Nordisk have led to adjustments in their semaglutide pricing and availability. As of April 2026, Hims offers compounded semaglutide starting at approximately $199 per month. Their medical consultations tend to be shorter than competitors, averaging around eight minutes, which is a drawback for patients who want more thorough evaluations. Foundayo has been added to their platform but is currently listed as limited availability in some states.

Noom Med

Noom's integration of GLP-1 medications with their behavioral coaching platform makes them a standout for patients who want comprehensive support beyond just the prescription. Pricing starts at approximately $249 per month for medication plus coaching. The medical consultations are thorough, and the ongoing behavioral support is genuinely useful. The downside is cost, as you are paying a premium for the coaching component. Noom has added Foundayo as an option and positions it as an entry point for patients new to GLP-1 therapy.

Found

Found offers a personalized approach with multiple medication options and board-certified obesity medicine specialists. Their pricing ranges from $129 to $399 per month depending on the medication and plan tier. Found has been quick to adopt Foundayo and offers it alongside injectable options. Their platform includes metabolic testing recommendations and integrates with popular fitness trackers for a more data-driven approach to weight management.

Other Notable Providers

Several other platforms deserve mention. Calibrate continues to offer a premium, insurance-first model with strong clinical outcomes data. PlushCare and Sesame both provide GLP-1 prescriptions through their general telehealth platforms at competitive prices. Newer entrants like Mochi Health and Henry Meds have gained traction with aggressive pricing on compounded medications.

The Hims and Novo Nordisk Situation

The evolving relationship between Hims and Novo Nordisk has been one of the biggest stories in the telehealth GLP-1 space. Initial partnership discussions raised hopes for preferential pricing on brand-name semaglutide, but the arrangement has been more complex in practice. As of April 2026, Hims continues to rely primarily on compounded semaglutide for its weight loss program, with brand-name options available at higher price points. Patients considering Hims should verify current medication sourcing and pricing before enrolling.

Foundayo Availability Across Platforms

The approval of Foundayo has prompted a rapid scramble among telehealth providers to add it to their offerings. As of early April, most major platforms have either launched Foundayo or announced imminent availability. The pricing across platforms has been relatively consistent, clustering around $149 for self-pay patients, reflecting Eli Lilly's suggested retail pricing strategy. The main differentiator between providers at this point is how well they integrate Foundayo into their existing care protocols and whether their physicians have experience with the new medication's titration schedule.

What to Look for in a Provider

Beyond pricing and medication availability, consider these factors when choosing a telehealth GLP-1 provider:

• Physician credentials: Board-certified obesity medicine specialists or endocrinologists provide better care than general practitioners for weight management.
• Follow-up protocols: Monthly check-ins at minimum, with clear escalation procedures for side effects or complications.
• Cancellation policies: Avoid platforms that lock you into long-term contracts or make cancellation difficult.
• Lab work requirements: Providers that require baseline and periodic lab work are practicing more responsible medicine.

We recommend cross-referencing provider claims with GLP-1 Watchdog, which independently verifies legitimacy and tracks safety records across the industry. This is especially important for newer or lesser-known platforms where patient reviews are still limited.

Our Recommendation

There is no single best provider for everyone. Budget-conscious patients may gravitate toward platforms offering compounded medications at lower prices, while those prioritizing comprehensive care will benefit from premium programs with dedicated support teams. The most important thing is to verify that any platform you choose maintains proper licensing, employs qualified physicians, and sources its medications from reputable suppliers. Do your research, ask questions, and do not let aggressive marketing override careful evaluation of the medical care being offered.